<DOC>
	<DOC>NCT01373619</DOC>
	<brief_summary>Heart failure with normal ejection fraction is often under diagnosed and certainly under treated in hemodialyzed patients. Because of the benefit of reducing heart rate, ivabradine, a pure heart-rate lowering agent without effects on blood pressure, is of potential therapeutic utility.</brief_summary>
	<brief_title>Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>hemodialyzed patients signs and symptoms of heart failure with normal ejection fraction sinus rhythm atrial fibrillation/atrial flutter valvular heart disease unstable angina hospitalization for heart failure prior 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Heart failure with normal ejection fraction</keyword>
	<keyword>hemodialysis patients</keyword>
	<keyword>ivabradine</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>NYHA class</keyword>
	<keyword>6-minutes walking test</keyword>
</DOC>